DURECT Corporation (NASDAQ: DRRX)
$1.37
+0.0150 ( +1.11% ) 25.5K
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
Market Data
Open
$1.37
Previous close
$1.35
Volume
25.5K
Market cap
$42.21M
Day range
$1.30 - $1.40
52 week range
$0.47 - $5.04
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 62 | Nov 14, 2023 |
8-k | 8K-related | 13 | Nov 13, 2023 |
8-k | 8K-related | 29 | Nov 07, 2023 |
8-k | 8K-related | 13 | Sep 07, 2023 |
10-q | Quarterly Reports | 61 | Aug 10, 2023 |
8-k | 8K-related | 13 | Aug 09, 2023 |
8-k | 8K-related | 17 | Jul 21, 2023 |